{"url_path":"/sec/ccrn/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","accession_number":"0001628280-26-032542","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":1385,"has_tables":true,"body_markdown":"ccrn-20260331\n000114110312/312026Q1FALSEhttp://fasb.org/us-gaap/2025#ServiceMemberhttp://fasb.org/us-gaap/2025#ServiceMemberxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureccrn:segmentccrn:stateccrn:extension00011411032026-01-012026-03-3100011411032026-04-2400011411032026-03-3100011411032025-12-3100011411032025-01-012025-03-310001141103us-gaap:CommonStockMember2025-12-310001141103us-gaap:AdditionalPaidInCapitalMember2025-12-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001141103us-gaap:RetainedEarningsMember2025-12-310001141103us-gaap:CommonStockMember2026-01-012026-03-310001141103us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001141103us-gaap:RetainedEarningsMember2026-01-012026-03-310001141103us-gaap:CommonStockMember2026-03-310001141103us-gaap:AdditionalPaidInCapitalMember2026-03-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001141103us-gaap:RetainedEarningsMember2026-03-310001141103us-gaap:CommonStockMember2024-12-310001141103us-gaap:AdditionalPaidInCapitalMember2024-12-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001141103us-gaap:RetainedEarningsMember2024-12-3100011411032024-12-310001141103us-gaap:CommonStockMember2025-01-012025-03-310001141103us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001141103us-gaap:RetainedEarningsMember2025-01-012025-03-310001141103us-gaap:CommonStockMember2025-03-310001141103us-gaap:AdditionalPaidInCapitalMember2025-03-310001141103us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001141103us-gaap:RetainedEarningsMember2025-03-3100011411032025-03-310001141103srt:MinimumMember2026-01-012026-03-310001141103srt:MaximumMember2026-01-012026-03-310001141103us-gaap:EmployeeSeveranceMember2025-12-310001141103ccrn:ExitCostsMember2025-12-310001141103us-gaap:EmployeeSeveranceMember2026-01-012026-03-310001141103ccrn:ExitCostsMember2026-01-012026-03-310001141103us-gaap:EmployeeSeveranceMember2026-03-310001141103ccrn:ExitCostsMember2026-03-310001141103ccrn:LeaseCostsAndOtherDirectChargesMember2026-01-012026-03-310001141103ccrn:TemporaryStaffingServicesMemberccrn:NurseAndAlliedStaffingMember2026-01-012026-03-310001141103ccrn:TemporaryStaffingServicesMemberccrn:PhysicianStaffingMember2026-01-012026-03-310001141103ccrn:TemporaryStaffingServicesMember2026-01-012026-03-310001141103ccrn:OtherServicesMemberccrn:NurseAndAlliedStaffingMember2026-01-012026-03-310001141103ccrn:OtherServicesMemberccrn:PhysicianStaffingMember2026-01-012026-03-310001141103ccrn:OtherServicesMember2026-01-012026-03-310001141103ccrn:NurseAndAlliedStaffingMember2026-01-012026-03-310001141103ccrn:PhysicianStaffingMember2026-01-012026-03-310001141103ccrn:TemporaryStaffingServicesMemberccrn:NurseAndAlliedStaffingMember2025-01-012025-03-310001141103ccrn:TemporaryStaffingServicesMemberccrn:PhysicianStaffingMember2025-01-012025-03-310001141103ccrn:TemporaryStaffingServicesMember2025-01-012025-03-310001141103ccrn:OtherServicesMemberccrn:NurseAndAlliedStaffingMember2025-01-012025-03-310001141103ccrn:OtherServicesMemberccrn:PhysicianStaffingMember2025-01-012025-03-310001141103ccrn:OtherServicesMember2025-01-012025-03-310001141103ccrn:NurseAndAlliedStaffingMember2025-01-012025-03-310001141103ccrn:PhysicianStaffingMember2025-01-012025-03-310001141103ccrn:MintMedicalPhysicianStaffingLPAndLotusMedicalStaffingLLCMember2022-10-032022-10-030001141103ccrn:MintMedicalPhysicianStaffingLPAndLotusMedicalStaffingLLCMember2022-10-030001141103ccrn:MintMedicalPhysicianStaffingLPAndLotusMedicalStaffingLLCMember2024-01-012024-03-310001141103ccrn:MintMedicalPhysicianStaffingLPAndLotusMedicalStaffingLLCMember2025-01-012025-03-310001141103us-gaap:StockCompensationPlanMember2026-01-012026-03-310001141103us-gaap:StockCompensationPlanMember2025-01-012025-03-310001141103us-gaap:DatabasesMember2026-03-310001141103us-gaap:DatabasesMember2025-12-310001141103us-gaap:CustomerRelationshipsMember2026-03-310001141103us-gaap:CustomerRelationshipsMember2025-12-310001141103ccrn:NurseAndAlliedStaffingMember2026-03-310001141103ccrn:PhysicianStaffingMember2026-03-310001141103ccrn:SeniorSecuredAssetBasedLoanMemberus-gaap:LineOfCreditMember2026-03-310001141103ccrn:SeniorSecuredAssetBasedLoanMemberus-gaap:LineOfCreditMember2025-12-310001141103ccrn:SeniorSecuredAssetBasedLoanMember2019-10-252019-10-250001141103ccrn:SeniorSecuredAssetBasedLoanMember2019-10-250001141103ccrn:SeniorSecuredAssetBasedLoanMemberccrn:SwingLoansSublimitMember2019-10-250001141103ccrn:SeniorSecuredAssetBasedLoanMemberccrn:StandbyLettersOfCreditSublimitMember2019-10-250001141103ccrn:SeniorSecuredAssetBasedLoanMember2020-06-300001141103ccrn:SeniorSecuredAssetBasedLoanMember2021-03-0800011411032021-11-180001141103ccrn:SeniorSecuredAssetBasedLoanMember2022-03-210001141103ccrn:SeniorSecuredAssetBasedLoanMember2022-03-212022-03-210001141103ccrn:SeniorSecuredAssetBasedLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2022-03-212022-03-210001141103ccrn:SeniorSecuredAssetBasedLoanMember2024-07-290001141103ccrn:SeniorSecuredAssetBasedLoanMember2026-03-310001141103ccrn:SeniorSecuredAssetBasedLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2026-01-012026-03-310001141103ccrn:SeniorSecuredAssetBasedLoanMemberus-gaap:BaseRateMember2026-01-012026-03-310001141103ccrn:SeniorSecuredAssetBasedLoanMember2026-01-012026-03-310001141103us-gaap:FairValueInputsLevel1Member2026-03-310001141103us-gaap:FairValueInputsLevel1Member2025-12-310001141103ccrn:RepurchaseProgramMember2023-05-010001141103ccrn:RepurchaseProgramMember2026-01-012026-03-310001141103ccrn:RepurchaseProgramMember2025-01-012025-03-310001141103ccrn:RepurchaseProgramMember2026-03-310001141103ccrn:OmnibusPlanMember2024-05-140001141103us-gaap:RestrictedStockMember2025-12-310001141103us-gaap:PerformanceSharesMember2025-12-310001141103us-gaap:RestrictedStockMember2026-01-012026-03-310001141103us-gaap:PerformanceSharesMember2026-01-012026-03-310001141103us-gaap:RestrictedStockMember2026-03-310001141103us-gaap:PerformanceSharesMember2026-03-310001141103us-gaap:SellingGeneralAndAdministrativeExpensesMember2026-01-012026-03-310001141103ccrn:RestrictedStockAndPerformanceSharesMember2026-01-012026-03-310001141103us-gaap:SellingGeneralAndAdministrativeExpensesMember2025-01-012025-03-310001141103ccrn:RestrictedStockAndPerformanceSharesMember2025-01-012025-03-310001141103us-gaap:OperatingSegmentsMemberccrn:NurseAndAlliedStaffingMember2026-01-012026-03-310001141103us-gaap:OperatingSegmentsMemberccrn:PhysicianStaffingMember2026-01-012026-03-310001141103us-gaap:OperatingSegmentsMember2026-01-012026-03-310001141103us-gaap:CorporateNonSegmentMember2026-01-012026-03-310001141103us-gaap:OperatingSegmentsMemberccrn:NurseAndAlliedStaffingMember2025-01-012025-03-310001141103us-gaap:OperatingSegmentsMemberccrn:PhysicianStaffingMember2025-01-012025-03-310001141103us-gaap:OperatingSegmentsMember2025-01-012025-03-310001141103us-gaap:CorporateNonSegmentMember2025-01-012025-03-310001141103country:IN2026-01-012026-03-310001141103country:IN2025-01-012025-03-310001141103us-gaap:IntersegmentEliminationMember2026-01-012026-03-310001141103us-gaap:IntersegmentEliminationMember2025-01-012025-03-3100011411032025-10-012025-12-310001141103ccrn:ServicesProvidedEntitiesAffiliatedWithBoardMembersMemberus-gaap:RelatedPartyMember2026-01-012026-03-310001141103ccrn:ServicesProvidedEntitiesAffiliatedWithBoardMembersMemberus-gaap:RelatedPartyMember2025-01-012025-03-310001141103ccrn:ContractWithAFirmRelatedToAFormerEmployeeMemberus-gaap:SubsequentEventMember2026-04-012026-04-300001141103ccrn:KLCrissCrossIntermediateLLCAndKLCrissCrossMergerSubInc.Memberus-gaap:SubsequentEventMember2026-05-060001141103ccrn:KLCrissCrossIntermediateLLCAndKLCrissCrossMergerSubInc.Memberus-gaap:SubsequentEventMember2026-05-062026-05-06\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, DC 20549\n\n———————\n\nFORM 10-Q\n\n———————\n\n☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\nFor the Quarterly Period Ended March 31, 2026\n\nOr\n\n☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934\n\nFor the Transition Period From _________ to _________\n\n———————\n\nCROSS COUNTRY HEALTHCARE, INC.\n\n(Exact name of registrant as specified in its charter)\n\n———————\n\nDelaware0-3316913-4066229\n\n(State or other jurisdiction of\nIncorporation or organization)Commission\nfile number(I.R.S. Employer\nIdentification Number)\n\n5201 Congress Avenue, Suite 160\n\nBoca Raton, Florida 33487\n\n(Address of principal executive offices)(Zip Code)\n\n(561) 998-2232\n\n(Registrant’s telephone number, including area code)\n\nNot Applicable\n\n(Former name, former address and former fiscal year, if changed since last report)\n\n———————\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each classTrading SymbolName of each exchange on which registered\n\nCommon stock, par value $0.0001 per shareCCRNThe Nasdaq Stock Market\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No\n\nIndicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:\n\nLarge accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐\n\nSmaller reporting company ☐ Emerging growth company ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition\n\nperiod for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nThe registrant had outstanding 32,332,661 shares of common stock, par value $0.0001 per share, as of April 24, 2026.\n\nINFORMATION RELATING TO FORWARD-LOOKING STATEMENTS\n\n \n\nIn addition to historical information, this Quarterly Report on Form 10-Q contains statements relating to our future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and the Private Securities Litigation Reform Act of 1995, and are subject to the “safe harbor” created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “estimates”, “suggests”, “appears”, “seeks”, “will”, “could”, and variations of such words and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: the timing to consummate the proposed merger with KL Criss Cross Intermediate, LLC (Merger, as discussed below), the risk that a condition of closing of the proposed Merger may not be satisfied or that the closing of the proposed Merger might otherwise not occur, the risk that a regulatory approval that may be required for the proposed Merger is not obtained or is obtained subject to conditions that are not anticipated, the diversion of management time on transaction-related issues, risks related to disruption of management time from ongoing business operations due to the proposed Merger, the risk that any announcements relating to the proposed Merger could have adverse effects on the market price of the Company’s common stock, the risk that the proposed Merger and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with its suppliers and customers, the occurrence of any event, change, or other circumstance or condition that could give rise to the termination of the agreement and plan of merger that contemplates the Merger, including in circumstances requiring the Company to pay a termination fee, the risk that competing offers will be made, unexpected costs, charges or expenses resulting from the Merger, potential litigation relating to the Merger that could be instituted against the parties to the agreement and plan of merger or their respective directors, managers, or officers, including the effects of any outcomes related thereto, worldwide economic or political changes that affect the markets that the Company’s businesses serve, which could have an effect on demand for the Company’s services and impact the Company’s profitability, effects from global pandemics, epidemics, or other public health crises, changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement and customer needs, disruptions in the global credit and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs and trade restrictions, foreign currency volatility, swings in consumer confidence and spending, and the overall macroeconomic environment, the functioning of our information systems and the effect of cyber security risks and cyber incidents on our business, demand for the healthcare services that we provide, both nationally and in the regions in which we operate, leadership transitions and retention of key employees, our ability to attract and retain qualified nurses, physicians, and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, and outcomes of regulatory and legal proceedings, claims, and investigations, and other factors, including, without limitation, the risk factors set forth in Item 1A. “Risk Factors” in the Company’s Annual Report on Form 10-K (2025 Form 10-K) for the year ended December 31, 2025, as filed and updated in our subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission (SEC).\n\n \n\nAlthough we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date of this filing. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) our strategy, which is based in part on this analysis, will be successful. Except as may be required by law, the Company undertakes no obligation to update or revise forward-looking statements.\n\n \n\nAll references to “the Company”, “we”, “us”, “our”, or “Cross Country” in this Quarterly Report on Form 10-Q mean Cross Country Healthcare, Inc. and its consolidated subsidiaries.\n\nCROSS COUNTRY HEALTHCARE, INC.\n\n \n\nINDEX\n\n \n\nFORM 10-Q\n\n \n\nMarch 31, 2026\n\n PAGE\n\n[PART I. – FINANCIAL INFORMATION](#i3fe7ced4ca7a4cafae8eaad4df17523b_13)\n\n[1](#i3fe7ced4ca7a4cafae8eaad4df17523b_13)\n\n[Item 1.](#i3fe7ced4ca7a4cafae8eaad4df17523b_16)\n\n[Condensed Consolidated Financial Statements](#i3fe7ced4ca7a4cafae8eaad4df17523b_16)\n\n[1](#i3fe7ced4ca7a4cafae8eaad4df17523b_16)\n\n \n[Condensed Consolidated Balance Sheets (Unaudited)](#i3fe7ced4ca7a4cafae8eaad4df17523b_19)\n\n[1](#i3fe7ced4ca7a4cafae8eaad4df17523b_19)\n\n \n[Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)](#i3fe7ced4ca7a4cafae8eaad4df17523b_22)\n\n[2](#i3fe7ced4ca7a4cafae8eaad4df17523b_22)\n\n[Condensed Consolidated Statements of Stockholders’ Equity (Unaudited)](#i3fe7ced4ca7a4cafae8eaad4df17523b_25)\n\n[3](#i3fe7ced4ca7a4cafae8eaad4df17523b_25)\n\n \n[Condensed Consolidated Statements of Cash Flows (Unaudited)](#i3fe7ced4ca7a4cafae8eaad4df17523b_31)\n\n[4](#i3fe7ced4ca7a4cafae8eaad4df17523b_31)\n\n \n[Notes to Condensed Consolidated Financial Statements (Unaudited)](#i3fe7ced4ca7a4cafae8eaad4df17523b_34)\n\n[5](#i3fe7ced4ca7a4cafae8eaad4df17523b_34)\n\n[Item 2.](#i3fe7ced4ca7a4cafae8eaad4df17523b_88)\n\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#i3fe7ced4ca7a4cafae8eaad4df17523b_88)\n\n[23](#i3fe7ced4ca7a4cafae8eaad4df17523b_88)\n\n[Item 3.](#i3fe7ced4ca7a4cafae8eaad4df17523b_130)\n\n[Quantitative and Qualitative Disclosures About Market Risk](#i3fe7ced4ca7a4cafae8eaad4df17523b_130)\n\n[31](#i3fe7ced4ca7a4cafae8eaad4df17523b_130)\n\n[Item 4.](#i3fe7ced4ca7a4cafae8eaad4df17523b_133)\n\n[Controls and Procedures](#i3fe7ced4ca7a4cafae8eaad4df17523b_133)\n\n[31](#i3fe7ced4ca7a4cafae8eaad4df17523b_133)\n\n[PART II. – OTHER INFORMATION](#i3fe7ced4ca7a4cafae8eaad4df17523b_136)\n\n[32](#i3fe7ced4ca7a4cafae8eaad4df17523b_136)\n\n[Item 1.](#i3fe7ced4ca7a4cafae8eaad4df17523b_139)\n\n[Legal Proceedings](#i3fe7ced4ca7a4cafae8eaad4df17523b_139)\n\n[32](#i3fe7ced4ca7a4cafae8eaad4df17523b_139)\n\n[Item 1A.](#i3fe7ced4ca7a4cafae8eaad4df17523b_142)\n\n[Risk Factors](#i3fe7ced4ca7a4cafae8eaad4df17523b_142)\n\n[32](#i3fe7ced4ca7a4cafae8eaad4df17523b_142)\n\n[Item 2.](#i3fe7ced4ca7a4cafae8eaad4df17523b_1431)\n\n[Unregistered Sales of Equity Securities and Use of Proceeds](#i3fe7ced4ca7a4cafae8eaad4df17523b_1431)\n\n[32](#i3fe7ced4ca7a4cafae8eaad4df17523b_1431)\n\n[Item 5.](#i3fe7ced4ca7a4cafae8eaad4df17523b_145)\n\n[Other Information](#i3fe7ced4ca7a4cafae8eaad4df17523b_145)\n\n[32](#i3fe7ced4ca7a4cafae8eaad4df17523b_145)\n\n[Item 6.](#i3fe7ced4ca7a4cafae8eaad4df17523b_148)\n\n[Exhibits](#i3fe7ced4ca7a4cafae8eaad4df17523b_148)\n\n[34](#i3fe7ced4ca7a4cafae8eaad4df17523b_148)\n\n[Signatures](#i3fe7ced4ca7a4cafae8eaad4df17523b_151)\n\n[35](#i3fe7ced4ca7a4cafae8eaad4df17523b_151)\n\ni\n\nPART I. FINANCIAL INFORMATION"}